Brad Smith

Brad Smith is an experienced financial executive and board member in the biotechnology and medical device industries. Currently serving as a Board Member for eGenesis, Inc. and Lyra Therapeutics, Brad Smith has held significant financial leadership roles, including Chief Financial Officer at Homology Medicines, Inc. and Ocular Therapeutix, Inc., where responsibilities included overseeing IPOs and advancing medical innovations. With an extensive background that spans various companies focused on genetic medicines, neurodiagnostics, and healthcare technology, Brad Smith has demonstrated a commitment to transforming patient care through strategic financial management and operational excellence. Educational credentials include an MBA from the University of New Hampshire and a B.S. in Biology from Tufts University.